Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Havlir

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
AIDS Clinical Care|October 10, 2001
Adding two new drug classes improves outcome in salvage therapyD Havlir
New York State Journal of Medicine|December 1, 1982
Typhoid feverT Brown, D Havlir
The Western Journal of Medicine|July 1, 1987
Biochemical and clinical aspects of amyloidosisD Havlir, L M Tierney
Drugs|January 1, 1995
Early versus delayed treatment of HIV infection. Zidovudine should be given before symptoms developD D Richman, D Havlir
Annals of Internal Medicine|October 1, 1994
Uveitis associated with rifabutin prophylaxisD Havlir, F Torriani, M Dubé
Journal of the American Geriatrics Society|January 1, 1989
Do not resuscitate discussions in a hospital-based home care programD Havlir, L Brown, G K Rousseau
Journal of Clinical Microbiology|July 1, 1993
Reproducibility of lysis-centrifugation cultures for quantification of Mycobacterium avium complex bacteremiaD Havlir, C A Kemper, S C Deresinski
The Journal of Infectious Diseases|November 1, 1995
A pilot study to evaluate the development of resistance to nevirapine in asymptomatic human immunodeficiency virus-infected patients with CD4 cell counts of > 500/mm3: AIDS Clinical Trials Group Protocol 208D Havlir, M M McLaughlin, D D Richman
Blood|August 8, 1998
Aberrant and unstable expression of immunoglobulin genes in persons infected with human immunodeficiency virusA Bessudo, L Rassenti, D Havlir, et al.
Journal of Virology|January 1, 1996
Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivoH Zhang, G Dornadula, Y Wu, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
AIDS Clinical Care|October 10, 2001
Adding two new drug classes improves outcome in salvage therapyD Havlir
New York State Journal of Medicine|December 1, 1982
Typhoid feverT Brown, D Havlir
The Western Journal of Medicine|July 1, 1987
Biochemical and clinical aspects of amyloidosisD Havlir, L M Tierney
Drugs|January 1, 1995
Early versus delayed treatment of HIV infection. Zidovudine should be given before symptoms developD D Richman, D Havlir
Annals of Internal Medicine|October 1, 1994
Uveitis associated with rifabutin prophylaxisD Havlir, F Torriani, M Dubé
Journal of the American Geriatrics Society|January 1, 1989
Do not resuscitate discussions in a hospital-based home care programD Havlir, L Brown, G K Rousseau
Journal of Clinical Microbiology|July 1, 1993
Reproducibility of lysis-centrifugation cultures for quantification of Mycobacterium avium complex bacteremiaD Havlir, C A Kemper, S C Deresinski
The Journal of Infectious Diseases|November 1, 1995
A pilot study to evaluate the development of resistance to nevirapine in asymptomatic human immunodeficiency virus-infected patients with CD4 cell counts of > 500/mm3: AIDS Clinical Trials Group Protocol 208D Havlir, M M McLaughlin, D D Richman
Blood|August 8, 1998
Aberrant and unstable expression of immunoglobulin genes in persons infected with human immunodeficiency virusA Bessudo, L Rassenti, D Havlir, et al.
Journal of Virology|January 1, 1996
Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivoH Zhang, G Dornadula, Y Wu, et al.
Pageof 4